Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04650243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

Study acronym: UDCA PBC
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 1, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Oct 2024 to May 2025 Start date: Mar 21, 2020 to Jan 21, 2020 · Eligibility criteria shortened, about 7 words · Study description expanded, about 1 word · 1 morev3 Show 4 more changesShow less
    • Start date: Mar 21, 2020 to Jan 21, 2020
    • Eligibility criteria shortened, about 7 words
    • Study description expanded, about 1 word
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study title shortened, about 6 wordsv2 See this version in full on ClinicalTrials.gov ↗
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study explores the feasibility of the reducing medication regimen for Ursodeoxycholic Acid(UDCA) in the treatment of primary biliary cholangitis. The participants will be distributed randomly into two experimental groups and one control group. The two experimental groups will receive reduced dosage of UDCA at different level, while the control group will receive standard dosage of UDCA. The effect of therapy will be evaluated every three months.
Trial Details
NCT Number NCT04650243
Lead Sponsor Peking Union Medical College Hospital
Conditions Primary Biliary Cholangitis
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov